| Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer LA Rojas, Z Sethna, KC Soares, C Olcese, N Pang, E Patterson, J Lihm, ... Nature 618 (7963), 144-150, 2023 | 273 | 2023 |
| ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity JA Moral, J Leung, LA Rojas, J Ruan, J Zhao, Z Sethna, A Ramnarain, ... Nature 579 (7797), 130-135, 2020 | 268 | 2020 |
| Inferring processes underlying B-cell repertoire diversity Y Elhanati, Z Sethna, Q Marcou, CG Callan Jr, T Mora, AM Walczak Philosophical Transactions of the Royal Society B: Biological Sciences 370 …, 2015 | 214 | 2015 |
| OLGA: fast computation of generation probabilities of B-and T-cell receptor amino acid sequences and motifs Z Sethna, Y Elhanati, CG Callan Jr, AM Walczak, T Mora Bioinformatics 35 (17), 2974-2981, 2019 | 174 | 2019 |
| Predicting the spectrum of TCR repertoire sharing with a data‐driven model of recombination Y Elhanati, Z Sethna, CG Callan Jr, T Mora, AM Walczak Immunological reviews 284 (1), 167-179, 2018 | 120 | 2018 |
| Neoantigen quality predicts immunoediting in survivors of pancreatic cancer M Łuksza, ZM Sethna, LA Rojas, J Lihm, B Bravi, Y Elhanati, K Soares, ... Nature 606 (7913), 389-395, 2022 | 99 | 2022 |
| Population variability in the generation and selection of T-cell repertoires Z Sethna, G Isacchini, T Dupic, T Mora, AM Walczak, Y Elhanati PLOS Computational Biology 16 (12), e1008394, 2020 | 51 | 2020 |
| Insights into immune system development and function from mouse T-cell repertoires Z Sethna, Y Elhanati, CR Dudgeon, CG Callan Jr, AJ Levine, T Mora, ... Proceedings of the National Academy of Sciences 114 (9), 2253-2258, 2017 | 40 | 2017 |
| Fundamental immune–oncogenicity trade-offs define driver mutation fitness D Hoyos, R Zappasodi, I Schulze, Z Sethna, KC de Andrade, DF Bajorin, ... Nature 606 (7912), 172-179, 2022 | 30 | 2022 |
| Phase I trial of adjuvant autogene cevumeran, an individualized mRNA neoantigen vaccine, for pancreatic ductal adenocarcinoma. VP Balachandran, LA Rojas, Z Sethna, K Soares, E Derhovanessian, ... Journal of Clinical Oncology 40 (16_suppl), 2516-2516, 2022 | 24 | 2022 |
| Accelerating multidimensional NMR and MRI experiments using iterated maps MA Frey, ZM Sethna, GA Manley, S Sengupta, KW Zilm, JP Loria, ... Journal of Magnetic Resonance 237, 100-109, 2013 | 13 | 2013 |
| Generative models of T-cell receptor sequences G Isacchini, Z Sethna, Y Elhanati, A Nourmohammad, AM Walczak, ... Physical Review E 101 (6), 062414, 2020 | 10 | 2020 |
| GeneVector: Identification of transcriptional programs using dense vector representations defined by mutual information N Ceglia, Z Sethna, F Uhlitz, V Bojilova, N Rusk, B Burman, A Chow, ... bioRxiv, 2022.04. 22.487554, 2022 | 6 | 2022 |
| Identification of transcriptional programs using dense vector representations defined by mutual information with GeneVector N Ceglia, Z Sethna, SS Freeman, F Uhlitz, V Bojilova, N Rusk, B Burman, ... Nature Communications 14 (1), 4400, 2023 | 1 | 2023 |
| Author Correction: Fundamental immune–oncogenicity trade-offs define driver mutation fitness D Hoyos, R Zappasodi, I Schulze, Z Sethna, KC de Andrade, DF Bajorin, ... Nature 606 (7914), E5, 2022 | 1 | 2022 |
| 824 High quality neoantigens are immunoedited in long-term pancreatic cancer survivors Z Sethna, M Luksza, L Rojas, K Soares, J Leung, J Lihm, D Hoyos, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | 1 | 2021 |
| Characterizing the T cell response to a personalized cancer vaccine Z Sethna Bulletin of the American Physical Society, 2024 | | 2024 |
| TCRi: Information theoretic metrics for single cell RNA and TCR sequencing in cancer N Ceglia, ZM Sethna, Y Elhanati, B Burman, A Chow, D Zamarin, ... bioRxiv, 2022.10. 01.510457, 2022 | | 2022 |
| Fundamental immune-oncogenicity trade-offs define driver mutation fitness (vol 606, pg 172, 2022) D Hoyos, R Zappasodi, I Schulze, Z Sethna, KC de Andrade, DF Bajorin, ... Nature, 2022 | | 2022 |
| Abstract PR-003: High quality neoantigens are immunoedited in long-term pancreatic cancer survivors LA Rojas, M Łuksza, ZM Sethna, K Soares, J Leung, J Lihm, D Hoyos, ... Cancer Research 81 (22_Supplement), PR-003-PR-003, 2021 | | 2021 |
Yuval ElhanatiMemorial Sloan Kettering Cancer CenterDirección de correo verificada de mskcc.org
